Thoas Fioretos

9.6k total citations · 1 hit paper
153 papers, 5.6k citations indexed

About

Thoas Fioretos is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thoas Fioretos has authored 153 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Hematology, 58 papers in Molecular Biology and 45 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thoas Fioretos's work include Acute Myeloid Leukemia Research (65 papers), Chronic Myeloid Leukemia Treatments (58 papers) and Acute Lymphoblastic Leukemia research (45 papers). Thoas Fioretos is often cited by papers focused on Acute Myeloid Leukemia Research (65 papers), Chronic Myeloid Leukemia Treatments (58 papers) and Acute Lymphoblastic Leukemia research (45 papers). Thoas Fioretos collaborates with scholars based in Sweden, United States and Denmark. Thoas Fioretos's co-authors include Bertil Johansson, Felix Mitelman, Henrik Lilljebjörn, Fredrik Mertens, Carin Lassen, Mattias Höglund, Anna Andersson, Kajsa Paulsson, Mikael Behrendtz and Marianne Rissler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Thoas Fioretos

151 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The emerging complexity of gene fusions in cancer

2015 464 citations Bertil Johansson, Thoas Fioretos et al. profile →

Peers

Countries citing papers authored by Thoas Fioretos

Since Specialization

Citations

This map shows the geographic impact of Thoas Fioretos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thoas Fioretos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thoas Fioretos more than expected).

Fields of papers citing papers by Thoas Fioretos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thoas Fioretos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thoas Fioretos. The network helps show where Thoas Fioretos may publish in the future.

Co-authorship network of co-authors of Thoas Fioretos

This figure shows the co-authorship network connecting the top 25 collaborators of Thoas Fioretos. A scholar is included among the top collaborators of Thoas Fioretos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thoas Fioretos. Thoas Fioretos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes 2025 ·Nature Communications ·Henrik Lilljebjörn, (unknown), (unknown), Rasmus Henningsson, Marianne Rissler, Niklas Landberg, (unknown), Sofia von Palffy, (unknown), (unknown), Jonathan Desponds, Xiangfu Zhong, Gunnar Juliusson, Vladimir Lazarević, Sören Lehmann, Magnus Fontes, Helena Ågerstam, Carl Sandén, Christina Orsmark‐Pietras, Thoas Fioretos	0
2	Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia 2025 ·Nature Cancer ·Carl Sandén, Niklas Landberg, (unknown), (unknown), Shruti Daga, (unknown), (unknown), Sofia von Palffy, Marianne Rissler, Vladimir Lazarević, Gunnar Juliusson, Mats Ohlin, Axel Hyrenius‐Wittsten, Christina Orsmark‐Pietras, Henrik Lilljebjörn, Helena Ågerstam, Thoas Fioretos	0
3	Sub-Nanomolar Detection of Oligonucleotides Using Molecular Beacons Immobilized on Lightguiding Nanowires 2024 ·Nanomaterials ·T. Johansson, (unknown), (unknown), (unknown), Björn Agnarsson, Roberto Munita, Thoas Fioretos, Henrik Lilljebjörn, Heiner Linke, Fredrik Höök, Christelle N. Prinz	3
4	Activating mutations remodel the chromatin accessibility landscape to drive distinct regulatory networks in KMT2A‐rearranged acute leukemia 2024 ·HemaSphere ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anders Castor, Hanne Vibeke Marquart, Birgitte Lausen, Thoas Fioretos, Axel Hyrenius‐Wittsten, Anna Andersson	4
5	Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases 2024 ·Blood ·(unknown), Rasmus Henningsson, (unknown), (unknown), (unknown), Helena Ågerstam, Carl Sandén, Marianne Rissler, Anders Castor, Hanne Vibeke Marquart, Signe Modvig, Kajsa Paulsson, Cornelis Jan Pronk, Kjeld Schmiegelow, Axel Hyrenius‐Wittsten, Christina Orsmark‐Pietras, Henrik Lilljebjörn, Thoas Fioretos	3
6	Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling 2024 ·Cell Reports ·James K. Fields, Elin Jaensson Gyllenbäck, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sara Rattik, (unknown), Maria W. Flowers, (unknown), Nils Hansen, Thoas Fioretos, (unknown), David Liberg, Daniel Deredge, Eric J. Sundberg	7
7	Micro-costing of genetic diagnostics in acute leukemia in Sweden: from standard-of-care to whole-genome sequencing 2024 ·Journal of Medical Economics ·(unknown), Valtteri Wirta, Christina Orsmark‐Pietras, Lucia Cavelier, Thoas Fioretos, Gisela Barbany, Linda Olsson, Tatjana Pandzic, Anna Staffas, Richard Rosenquist, Lars‐Åke Levin	3
8	Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity 2023 ·Blood Advances ·(unknown), (unknown), (unknown), Somadri Ghosh, Leal Oburoglu, (unknown), (unknown), Mats Ehinger, (unknown), (unknown), Henrik Lilljebjörn, Jörg Cammenga, Cornelis Jan Pronk, Vladimir Lazarević, Thoas Fioretos, Anna Andersson, Niels‐Bjarne Woods, Marcus Järås	15
9	Clonal competition within complex evolutionary hierarchies shapes AML over time 2020 ·Nature Communications ·Carl Sandén, Henrik Lilljebjörn, Christina Orsmark‐Pietras, Rasmus Henningsson, (unknown), Niklas Landberg, (unknown), Sofia von Palffy, (unknown), Carl Högberg, Marianne Rissler, David Gisselsson, Vladimir Lazarević, Gunnar Juliusson, Helena Ågerstam, Thoas Fioretos	21
10	13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking 2020 ·Blood ·Minjun Yang, (unknown), E. L. Woodward, Nicolas Duployez, Linda Olsson, Jonas Ungerbäck, Mikael Sigvardsson, Markéta Žaliová, Jan Zuna, Thoas Fioretos, Bertil Johansson, Karolin H. Nord, Kajsa Paulsson	38
11	Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia 2019 ·Nature Communications ·Minjun Yang, Mattias Vesterlund, Ioannis Siavelis, (unknown), Anders Castor, Thoas Fioretos, Rozbeh Jafari, Henrik Lilljebjörn, Duncan T. Odom, Linda Olsson, (unknown), E. L. Woodward, Louise Harewood, Janne Lehtiö, Kajsa Paulsson	58
12	Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia 2018 ·Leukemia ·Rebeqa Gunnarsson, Sebastian DiLorenzo, Kristina Lundin, Linda Olsson, Andrea Biloglav, Henrik Lilljebjörn, Marianne Rissler, Per Wahlberg, Anders Lundmark, Anders Castor, Mikael Behrendtz, Thoas Fioretos, Kajsa Paulsson, Anders Isaksson, Bertil Johansson	5
13	New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia 2017 ·Blood ·Henrik Lilljebjörn, Thoas Fioretos	55
14	A field guide for cancer diagnostics using cell‐free DNA: From principles to practice and clinical applications 2017 ·Genes Chromosomes and Cancer ·Anna‐Lena Volckmar, Holger Sültmann, Anja Lisa Riediger, Thoas Fioretos, Peter Schirmacher, Volker Endris, Albrecht Stenzinger, Steffen Dietz	146
15	Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy 2016 ·Clinical Cancer Research ·Noortje Thielen, Johan Richter, (unknown), Gisela Barbany, Thoas Fioretos, Francis J. Giles, Bjørn Tore Gjertsen, Andreas Hochhaus, Gerrit Jan Schuurhuis, Sieghart Sopper, Leif Stenke, Sarah Thunberg, Dominik Wolf‎, Gert J. Ossenkoppele, Kimmo Porkka, Jeroen J. W. M. Janssen, Satu Mustjoki	14
16	Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia 2016 ·Nature Communications ·Henrik Lilljebjörn, Rasmus Henningsson, Axel Hyrenius‐Wittsten, Linda Olsson, Christina Orsmark‐Pietras, Sofia von Palffy, Maria Askmyr, Marianne Rissler, Martin Schrappe, Gunnar Cario, Anders Castor, Cornelis Jan Pronk, Mikael Behrendtz, Felix Mitelman, Bertil Johansson, Kajsa Paulsson, Anna Andersson, Magnus Fontes, Thoas Fioretos	191
17	The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia 2015 ·Nature Genetics ·Kajsa Paulsson, Henrik Lilljebjörn, Andrea Biloglav, Linda Olsson, Marianne Rissler, Anders Castor, Gisela Barbany, Linda Fogelstrand, Ann Nordgren, Helene Sjögren, Thoas Fioretos, Bertil Johansson	111
18	An improved method for detecting and delineating genomic regions with altered gene expression in cancer 2008 ·Genome biology ·Björn Nilsson, Mikael Johansson, Anders Heyden, Sven Nelander, Thoas Fioretos	14
19	Fusion gene‐mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome 2007 ·Genes Chromosomes and Cancer ·Helena Ågerstam, Henrik Lilljebjörn, Carin Lassen, Agneta Swedin, Johan Richter, Peter Vandenberghe, Bertil Johansson, Thoas Fioretos	41
20	Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations 2005 ·Proceedings of the National Academy of Sciences ·Anna Andersson, Tor Olofsson, David Lindgren, Björn Nilsson, (unknown), Patrik Edén, Carin Lassen, Johan Råde, Magnus Fontes, Helena Mörse, Jesper Heldrup, Mikael Behrendtz, Felix Mitelman, Mattias Höglund, Bertil Johansson, Thoas Fioretos	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact